• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

FDA Wants to Use EHRs to Track Drug Safety

Article

The FDA is offering a grant of up to $1 million to turn large amounts of electronic health record data into usable figures highlighting postmarket risks of various drugs.

The FDA is offering a grant of up to $1 million to turn large amounts of electronic health record (EHR) data into usable figures highlighting postmarket risks of various drugs. The goal is for the agency to be able to perform continuous risk/benefit assessments of drugs after they hit the market.

Eligibility for the grant is limited to the Reagan-Udall Foundation through its Innovations in Medical Evidence Development and Surveillance-Methods program.

The FDA announced plans in January to build a database of EHRs as part of the Mini-Sentinel project. There are roughly 150 million patient records online, and the agency is hoping the foundation will develop analytical processes that can turn that raw data into clear safety trends.

Read more at FDA News: http://bit.ly/1Ju7bFy

Related Videos
Nihar Desai, MD, MPH
Dr Xin Hu
Douglas Flora, MD, FACCC
Dr Xin Hu
Dr Xin Hu
Douglas Flora, MD, FACCC
Nate Lighthizer, OD, FAAO
Jeffrey Stark, MD, vice president and head of medical immunology at UCB.
Carrie Kozlowski, OT, MBA, Upfront Healthcare
Masanori Aikawa, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.